[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Jaffari et al., 2013 - Google Patents

Rapid characterisation of the inherent dispersibility of respirable powders using dry dispersion laser diffraction

Jaffari et al., 2013

View HTML
Document ID
7316329388144213912
Author
Jaffari S
Forbes B
Collins E
Barlow D
Martin G
Murnane D
Publication year
Publication venue
International journal of pharmaceutics

External Links

Snippet

Understanding and controlling powder de-agglomeration is of great importance in the development of dry powder inhaler (DPI) products. Dry dispersion laser diffraction measures particle size readily under controlled dispersing conditions, but has not been exploited fully …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Similar Documents

Publication Publication Date Title
Jaffari et al. Rapid characterisation of the inherent dispersibility of respirable powders using dry dispersion laser diffraction
Kaialy et al. Influence of lactose carrier particle size on the aerosol performance of budesonide from a dry powder inhaler
Zhou et al. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders
Zhou et al. Improving aerosolization of drug powders by reducing powder intrinsic cohesion via a mechanical dry coating approach
Guenette et al. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design
Flament et al. The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers
Kinnunen et al. An investigation into the effect of fine lactose particles on the fluidization behaviour and aerosolization performance of carrier-based dry powder inhaler formulations
Kou et al. Physico-chemical aspects of lactose for inhalation
Young et al. Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems
Stank et al. Physico-chemical characterisation of surface modified particles for inhalation
Thalberg et al. Modeling dispersion of dry powders for inhalation. The concepts of total fines, cohesive energy and interaction parameters
Young et al. The influence of drug loading on formulation structure and aerosol performance in carrier based dry powder inhalers
Hertel et al. The influence of high shear mixing on ternary dry powder inhaler formulations
Nguyen et al. Towards quantitative prediction of the performance of dry powder inhalers by multi-scale simulations and experiments
Kaialy et al. Antisolvent crystallisation is a potential technique to prepare engineered lactose with promising aerosolisation properties: effect of saturation degree
Saleem et al. Prediction of dry powder inhaler formulation performance from surface energetics and blending dynamics
Hertel et al. Particle engineered mannitol for carrier-based inhalation–A serious alternative?
Thalberg et al. Dispersibility of lactose fines as compared to API in dry powders for inhalation
Adi et al. Agglomerate strength and dispersion of pharmaceutical powders
Zhang et al. Effect of powder properties on the aerosolization performance of nanoporous mannitol particles as dry powder inhalation carriers
Behara et al. An approach to characterising the cohesive behaviour of powders using a flow titration aerosolisation based methodology
Jetzer et al. Probing the particulate microstructure of the aerodynamic particle size distribution of dry powder inhaler combination products
Thalberg et al. Controlling the performance of adhesive mixtures for inhalation using mixing energy
Ung et al. Design of spray dried insulin microparticles to bypass deposition in the extrathoracic region and maximize total lung dose
Mangal et al. Relationship between the cohesion of guest particles on the flow behaviour of interactive mixtures